General Information of Drug (ID: DM67LGP)

Drug Name
MLC901
Synonyms NeuroAiD
Indication
Disease Entry ICD 11 Status REF
Alzheimer disease 8A20 Phase 2 [1]
Cross-matching ID
TTD ID
DYB14S

References

1 ClinicalTrials.gov (NCT03038035) The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study : Assessing the Safety and Efficacy of Neuroaid II (MLC901) in Patients With Mild to Moderate Alzheimer's Disease Stable on Cholinesterase Inhibitors or Memantine: A Randomized, Double Blind, Placebo Controlled Trial. U.S.National Institutes of Health.